A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers
Condition(s):Healthy VolunteersLast Updated:September 30, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Healthy VolunteersLast Updated:September 30, 2022Completed
Condition(s):Advanced Solid TumorsLast Updated:December 29, 2022Recruiting
Condition(s):Symptomatic Aortic StenosisLast Updated:September 28, 2022Recruiting
Condition(s):Chronic Lymphocytic Leukaemia; Small Lymphocytic Lymphoma; Mantle Cell LymphomaLast Updated:September 30, 2022Recruiting
Condition(s):Amyloid Transthyretin CardiomyopathyLast Updated:June 14, 2022Recruiting
Condition(s):HealthyLast Updated:January 12, 2022Completed
Condition(s):Safety Issues; Tolerance; Idiopathic Pulmonary Fibrosis; Pulmonary HypertensionLast Updated:June 22, 2022Recruiting
Condition(s):Metastatic Solid Tumor; Lymphoma; Myeloproliferative Neoplasms (MPN)Last Updated:June 10, 2022Active, not recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:November 25, 2022Recruiting
Condition(s):Immunoglobulin A Nephropathy; IgAN – IgA Nephropathy; IgA NephropathyLast Updated:March 6, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.